SEC Form 4 · accession 0001209191-16-154699
ANTARES PHARMA, INC. · ATRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred M Powell
Officer — Senior Vice President & CFO
Period of report
Dec 9, 2016
Accepted (ET)
Dec 12, 2016 · 4:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 9, 2016 | P | 100,000 | $2.025 | A | 100,000 | D |
Table II — derivative securities
No Table II lines on this filing.